Multi-Chem

Results

Multi-Chem raises FY2022 dividends despite lower earnings

Multi-Chem plans to pay a total of 17.7 cents for FY2022, versus 11.1 cents for FY2021

Insider moves

Dyna-Mac CEO tops up stake amid new orders; directors of Multi-Chem pick up more shares

Dyna-Mac continues to receive very strong enquiries that may potentially add to its order book

Results

Multi-Chem reports 28% y-o-y jump in 2HFY2021 earnings

The company plans to pay a final dividend of 6.9 cents, bringing FY2021 total to 11.1 cents
Alliance Healthcare chairman, Multi-Chem CEO raise stakes in respective companies - THE EDGE SINGAPORE

Insider moves

Alliance Healthcare chairman, Multi-Chem CEO raise stakes in respective companies

On Sept 22, Alliance Healthcare completed the acquisition of SGIMED
Broker's Digest: Samudera, Raffles Medical, Multi-Chem, iX Biopharma, Hong Leong Asia - THE EDGE SINGAPORE

Broker's Calls

Broker's Digest: Samudera, Raffles Medical, Multi-Chem, iX Biopharma, Hong Leong Asia

See the analysts' recommendations and target prices here.
CGS-CIMB takes a closer look at Multi-Chem in unrated report - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB takes a closer look at Multi-Chem in unrated report

Dividend yields for Multi-Chem have ranged from 3.2% to 4.7% between FY16 to FY20.
Brokers' Digest 962 - THE EDGE SINGAPORE

Broker's Calls

Brokers' Digest 962

See these six stocks this week, including Jumbo Group, Q&M Dental Group and Frasers Hospitality Trust.

Results

Multi-Chem's 1Q earnings up 81% to $2.8 mil on higher revenue

SINGAPORE (Apr 26): Multi-Chem saw its earnings jump 81% to $2.8 million for the 1Q ended March, from $1.5 million a year ago.

Results

Multi-Chem 3Q earnings tumble 70% to $0.8 mil

SINGAPORE (Oct 27): Multi-Chem posts a 70% drop in earnings to $765,000 for the 3Q ended September, from $2.6 million a year ago.
×